14 ms·
Break Up the Insulin Racket
- EwanG 11y agoAccording to the article, Pharmacy Benefit Managers are as much to blame for the increasing costs of drugs as the manufacturers. I suspect that's partly true, but I also suspect the "percentage of blame" is being ignored here.
- bcheung 11y agoA model that is more direct from business to customer sounds like it would eliminate costs. Too many people trying to put themselves in the middle and make a cut.
- maxerickson 11y agoWho cares about the percentage of blame? I think to start reducing costs in our health care system we have to fix every problem we see. Theoretically, the entity exists to work on behalf of the patient. A simple fix here would be to require them to pass any rebates they receive on to patients. That the rebates would go away under such a requirement is, uh, fine.
- refurb 11y agoNo offense, but the article got PBMs entirely wrong. Any savings from rebates is typically passed back to the one paying. In fact, it would be odd if an insurance company didn't have that in their contract. I'd say PBMs have done a ton on keeping drug costs down. Hell, look at HCV! Express Scripts cut a deal with Abbvie on their new HCV drug and excluded Solvadi and Harvoni from their formulary. What happened? Gilead came out and offered a 20-30% discount on their drug to pretty much every other PBM and insurance company.
- brandonmenc 11y agoThere are so many people on both insulin and government health insurance that it's probably in the taxpayers' interest to build an insulin factory to supply the low-end.
- bcheung 11y agoThat won't happen, the government is the one preventing it because of the patent restrictions. If the patents were limited then companies would spring up instantly to manufacture it cheaply.
- adventured 11y agoThey're also the ones holding back generics to a dramatic degree via the FDA approval process, which would stop a biosimilar insulin from making it through. The government has entirely rigged the game. The statistical change in approvals is so dramatic and inverted, as to be implausible to be anything but intentional fraud on the part of the FDA. (why fraud you might ask? deceit for monetary gain: user fees paid by big pharma) http://www.statnews.com/2015/12/29/generic-drugs-backlog/ http://www.statnews.com/2015/12/29/generic-drugs-backlog/
- mikeyouse 11y agoI had a similar thought a few years ago that it would have been in the government's interest to buy Pharmasset when they sold for $11B to Gilead based on the future potential of Sovaldi (the infamous $1,000/pill, 12-week treatment for Hepatitis C). The government through Medicare / Medicaid is currently spending upwards of $4B/year on the drug and private insurers and international buyers are spending billions more. It would've been an absolute net-win for humanity had the USGov or someone else just bought the company rather than giving Gilead billions in annual profits.
- maxerickson 11y agoThe problem is deciding where to put your billions without the benefit of hindsight. If Sovaldi hadn't worked out, the purchase would be hailed as a disaster.
- mikeyouse 11y agoYou're definitely right, but I think government should be taking more risk.. It's hard to fight off the 'Solyndra!' shouts when something goes wrong, and costs are hard to quantify when things go right (what's the $ return of all the USGov's investments in the early internet?) but braver politicians could pull it off and we'd all be better for it.
- deleted 11y ago[deleted]
- forrestthewoods 11y agoGenerally speaking companies "extend" their patent by making a slight tweak to get a new patent. But that doesn't stop their old patent from expiring. And the old formula from becoming open to a generic. So why aren't there generic versions of old formulations? Who cares if it doesn't have the latest tweak? The complain about such tweaks is that their minor and unimportant. Meaning the previous version should be just fine.
- CWuestefeld 11y agoJust one data point: I have Crohn's Disease. Up until a few years ago, I took Asacol for this. This is one of a whole class of drugs based on the active ingredient "mesalamine": Asacol is specialized in that it's got a coating that keeps it from dissolving until it gets to the colon. Somebody found that this coating (notice: not the drug itself, just an enteric coating) might be a risk for pregnant mothers - something that I will never be. So they stopped making Asacol, and came out with a new "Asacol HD", which is still good old-fashioned mesalamine, but with a slightly different enteric coating - and with a brand new patent. Although I don't have any evidence to support the idea, it seems suspicious that this revelation about the coating being questionable during pregnancy, came to light not very long before the expiration of the patent on original Asacol. So there exists a small group of patients (pregnant moms) who might have had trouble with original-packaging Asacol. Rather than putting these patients on other mesalamine meds (like Pentasa or Delzicol) for 9 months, that was parlayed into a need to discontinue the entire Asacol product and come out with a new one. In this case, it seems that a desire (or a pretense) to make something safe for all sub-groups, even those that are small and easily segmented, becomes the engine for renewing the patent, and thus keeping generics out of the market.
- roadnottaken 11y agoBut as forrestthewoods pointed out, if the improvements in the new version are so marginal, then you'd think there would be a booming market for the old version if it was cheaper (generic). So what's stopping the generic manufacturers from cranking out the old versions? Seems like there would be lots of money to be made, unless patients (the market) actually did value the incremental improvements and would likely chose not to purchase the original formulation.
- simonsarris 11y ago> In much of Europe, insulin costs about a sixth of what it does here. That’s because the governments play the role of pharmacy benefit managers. They negotiate with the manufacturer directly and have been very effective at driving down prices. In the United States, we rely on the private sector and a free market for drug pricing. Cartels are an emergent phenomenon[1] and it is in the interest of a fair market to not be "free market," whenever it leads to rackets. [1] https://news.ycombinator.com/item?id=3494224 https://news.ycombinator.com/item?id=3494224
- vlunkr 11y agoBut couldn't you argue that the problem is in the patent system, not in the free market? 3 companies holding on to patents longer than normal doesn't sound like a free market to me. As the article says, if the patents didn't exist, we could have a generic brands.
- tajen 11y agoPatents aren't free market, since they require the government to play a role (enforcement) in favour of patent holders. A free market wouldn't be able to protect the IP, it would use DRM and peer-to-peer contracts, and as soon as the receipe gets out, they'd be in for ther investment. A socialist government would define a type a company that is allowed to conduct medical research and fix the bounds within which the company can invest or the sale prices.
- Nutmog 11y agoThat's stretching the definition of free market a bit. You could apply it to real estate property rights too and argue that a corner shop isn't in a free market because the owner has paid for a monopoly on access to that building which is most suited to selling things from. His property rights are protected by the police to stop competitors sending their goons in to take over the building. The same goes for any business that owns any sort of valuable property, especially if their ownership gives them exclusive access to it. So I think a useful definition of free market has to include various property rights, including IP. As long as people can trade those rights among each other, whoever holds the patent would probably have spent a fair amount of money to either invent or buy it.
- tosseraccount 11y agoThe risk of diabetes is strongly associated with obesity, and even a modest weight loss has been reported to substantially decrease the diabetic risk. According to statistics from the US Center for Disease Control and Prevention, 55% of diabetic patients are obese and 85% are overweight - [http://www.sciencedirect.com/science/article/pii/S0899900712000731 http://www.sciencedirect.com/science/article/pii/S0899900712... ] Is it the drug companies or the sugary food makers running the racket?
- nightski 11y agoAhh, statistics. How do the 55% or 85% numbers compare with the population as a whole? Is it a significant increase? Is there evidence of a statistically significant correlation between obesity and being overweight? Are there any factors that might be involved that are also correlated with obesity but that might be the true cause? PS - Study recommends a ketogenic diet which I am very much in favor for. It has done wonders for me (ymmv). But I am still on the fence about being "overweight" being a direct cause of diabetes and not an effect.
- DenisM 11y ago>I am still on the fence about being "overweight" being a direct cause of diabetes and not an effect. The parent did not bring causation into the discussion, you did. You're right to doubt it. Metabolic syndrome is the common theme http://www.nhlbi.nih.gov/health/health-topics/topics/ms http://www.nhlbi.nih.gov/health/health-topics/topics/ms and it likely leads to both obesity and diabetes, among many other ailments.
- ferrari8608 11y agoMetabolic syndrome includes obesity and diabetes along with heart disease, cancer, and a few other conditions. It is not a cause but rather the result.
- nightski 11y agoI interpreted "even a modest weight loss has been reported to substantially decrease the diabetic risk" as causation. But you are right, he did not say it directly.
- ecobiker 11y agoA simple fix could go a long way - disallow really minor improvements and work hard to get rid of evergreening. http://www.nature.com/news/indian-court-rejects-novartis-patent-1.12717?WT.ec_id=NEWS-20130402 http://www.nature.com/news/indian-court-rejects-novartis-pat...
- dnautics 11y agoHow do you define "minor"? These insulins have dramatically different serum half lives (for example there are fast acting ones for postprandial administration, others that are optimized for pumps, etc) and so there is a clear pharmacological difference. Moreover, discovering these variants is nontrivial, as each insulin must be checked against igf-1 receptor cross reactivity, lest it become teratogenic. Making matters worse, the exact binding of insulin and igf-1 to their receptors is not known making this endeavor especially difficult to predict. What is not clear is whether these modifications are an over optimization over "the original". For each patient the cost/benefit calculation will be different and based on many variables.
- deleted 11y ago[deleted]
- ecobiker 11y agohttp://theconversation.com/explainer-evergreening-and-how-big-pharma-keeps-drug-prices-high-33623 http://theconversation.com/explainer-evergreening-and-how-bi... I'm not an expert and I can't comment on specifics. But I'm of the opinion that a small enhancement is not the same as an invention of a drug and it doesn't come anywhere close to extending the life of the patent - unless that tiny change actually makes a big different in effectiveness. Any good patent system should find a good balance between the two seemingly conflicting goals of incentivizing companies to innovate and keeping the price down for patients.
- dnautics 11y agoThese insulin changes are like the difference between a spanner and a torque wrench, or a spanner and a ratcheting wrench. The torque wrench is definitely more effective for certain use cases, as is the ratcheting wrench, both are nontrivial, but 99% of the time the spanner would do just fine / maybe be a bit more of a hassle.
- seivan 11y agoJust throwing this out there, I am not sure of this myself. But aren't there studies where you could do without insulin shots if you avoided carbohydrates while feeding on protein and fat?
- kefka 11y agoNope. There's a few things involved why this is a no. The brain can only run on glucose. Because of that, the liver produces glucose from 'whatever', including pure protein. Leftover glucose ends up in the body, which can only be dealt with insulin. Now, things like alcohol attack the glucose emitted by the liver, as it must handle alcohol before anything else. But no, at least for type 1s and t2's with severely degraded pancreatic function. For me, I'm recent T2 but handling it well with protein and fats to great effect (-40 lbs, normal blood sugar) since December 7. I'm sticking to roughly 'atkins style diet' to a great effect, called "Eating to the Meter".
- ferrari8608 11y agoThe brain and the rest of the body can run exceptionally well on ketones, which is the fuel produced by metabolizing fat. This is the fuel humans have thrived on for most of our history. True, there are a couple of functions of the body that require glucose. The liver is well capable of synthesizing the needed glucose from protein, a precess call gluconeogenesis. Consumption of carbohydrates and excess protein is not required at all for this process.
- deleted 11y ago[deleted]
- DrScump 11y agoThe brain can only run on glucose. False. Now, things like alcohol attack the glucose False, but it is true that the liver breaks down alcohol first, as a toxin.
- mikeytown2 11y agoI believe this is the study you're thinking about http://ajcn.nutrition.org/content/early/2015/07/29/ajcn.115.112581.short http://ajcn.nutrition.org/content/early/2015/07/29/ajcn.115.... "The LC diet, which was high in unsaturated fat and low in saturated fat, achieved greater improvements in the lipid profile, blood glucose stability, and reductions in diabetes medication requirements, suggesting an effective strategy for the optimization of T2D management." I haven't heard of any formal studies where they got off of medication 100%; I've only heard of n=1 studies (single person reporting) where that has happened. The most remarkable n=1 is this from a type 1 diabetic: https://www.reddit.com/r/keto/comments/2rnn9b/doctors_can_suck_it_im_staying_on_keto_for_the/ https://www.reddit.com/r/keto/comments/2rnn9b/doctors_can_su... but in this case the person is still on it which isn't a surprise as they are type 1.
- tehwalrus 11y agoIt's really weird to read this kind of article from outside the USA, where healthcare is a public service. (of course, here in the UK, the tories are doing their best to ruin the NHS, but it's still so much better than this).
- brandonmenc 11y agoEvery time there's a health care post people chime in with the useless comment, "this is really weird to those of us not in the USA." Jeez, really? Wow.
- remh 11y agoI agree with that. But, as a European, I also agree with the parent comment. It is weird in the sense that we could never think of something like that, things such as a "doughnut hole" where a few months a year you don't have an insurance. I currently live and work in the US, love it, love the country. I have the chance to have a great plan thanks to my company. But i'm not sure how much more I can keep tacitly approving this system.
- brandonmenc 11y ago> I also agree with the parent comment What's not to agree with? The parent comment is simply stating nothing more than a fact we're all well aware of - that we have a different system in the US.
- maxerickson 11y agoThe doughnut hole isn't that weird, a coverage was expanded, with a limit on how far it was expanded. The limitation is on spending, not related to the calendar beyond that: https://www.medicare.gov/part-d/costs/coverage-gap/part-d-coverage-gap.html https://www.medicare.gov/part-d/costs/coverage-gap/part-d-co... Of course once the annual limit is reached coverage is reduced for a period of time, but there will also be cases where the limit is not reached. And while it doesn't compare favorably to a simpler to access program that covers all expenses, enacting it didn't make anybody that ends up using it worse off.
- GirlProgrammer 11y agoThey need to separate the (at least) 60% of type-2 diabetic patients whose disease is caused by self-inflicted obesity from the people with type-1 diabetes (and the 10% of type-2 diabetic patients who aren't obese.) See this study on nih.gov: http://www.ncbi.nlm.nih.gov/pubmed/17227327 http://www.ncbi.nlm.nih.gov/pubmed/17227327 "60% of cases of [type 2] diabetes could have been prevented if everyone had been of normal weight." To those type-2 diabetics that are obese, they should be strongly encouraged to lose weight rather than depending on our insulin supply. I think it would be a good idea to rename obesity-induced diabetes as "Obesity Related Metabolic Syndrome" (ORMS) to separate those with type-1 or non-obese type-2 diabetes from those who chose the obese lifestyle and got sick.
- zwetan 11y agoin France, in UK, and probably rest of Europe people with Type 1 and 2 diabetes are taken in charge 100% that means whatever amount of insulin you need, you get it for free and it's not only the insulin, it's also all the rest: test strips, glycemic reader, etc. I'm pretty sure the article is wrong about "had Type 2 diabetes for over 30 years. She takes several injections of insulin each day." this more describe Type 1 situation anyway, I'm pretty sure the price of insulin went up also in Europe, except the government paid the bill, not the patient, a bit more civilised but still the problem stay the same: big pharma corporation are abusing the situation and make money from it, it is disgusting and criminal first, about the patent and why there is no generic insulin, read http://www.medscape.com/viewarticle/841669 http://www.medscape.com/viewarticle/841669 second, most people are uneducated about diabetes, they think it concern only fat people or other countries, and other BS like that nope, it is worldwide major public health problem, many studies show the amount of people with diabetes rising , for ex http://www.nytimes.com/2015/06/08/health/research/global-diabetes-rates-are-rising-as-obesity-spreads.html http://www.nytimes.com/2015/06/08/health/research/global-dia... "reported a 45 percent rise in the prevalence of diabetes worldwide from 1990 to 2013" finally, why it is disgusting and criminal for pharma corp to make ppl pay for insulin ? it as simple as that: if you don't take insulin you die, period. It's not curable, there is no alternative diet, nothing, zilch, nada and those big pharma corporation they made a business to profit from that, and when profit is not high enough, simple, raise the price.
- pascalmemories 11y agoType 2 diabetics often progress to insulin treatment as their pancreas becomes exhausted and ceases proper function. The low insulin sensitivity in type 2 means the pancreas produces large amounts of insulin in a futile attempt to reduce blood sugar. Initial treatments focus on insulin sensitizing agents to try and assist the natural insulin to be effective. Despite the amazing capabilities of the body, it eventually becomes too much and people have to start insulin replacement therapy at that point.
- zwetan 11y agono problem, it's like the honey moon period for a type 1 patient I was saying "maybe", in general I see type 2 ppl who are just on pills and have no need to take insulin, but yeah the diabetes can progress in different way, no problem with that
- narrator 11y agoI think the hardest thing for the American political system to grasp about our medical system is that spending more money is not the answer. We already spend 16% of GDP, about double what almost all other countries spend on health care and have worse outcomes. I'm glad that there's some new thinking going on here that may lead to some movement. Unfortunately, all the incentives are aligned such that everyone who is making a ton of money off the system lobbies to make even more.
- x5n1 11y agoAt the same time doctor's income is actually decreasing. So America has a lot of parasitic Capitalists adding little value but sucking billions of dollars out of the system. This sort of Capitalism does no one any good. A lot of that money is being sucked out by regulatory capture. Spending more money will lead to yet more money being lost to the same parasites which will simply find ways of increasing their ability to leech money from the system.
- maxerickson 11y agoIt's likely that doctors earning less is an important component of reducing heath care costs in the US. Of course we should try to make that happen by increasing the supply of doctors rather than mismanagement.
- jessriedel 11y agoDoctors make up less than 9% of total health care spending. The idea that you're going to make a dent in spending by cutting doctor salaries further is insane. They are the only fully knowledgable people in hospital, and because they are so overloaded they are making thousands of key decisions everyday in a rush. It's already conventional wisdom that you can't make nearly as much money as a doctor as you use to, and so the best and brightest students are skipping it for more lucrative fields. This damage will take decades to be undone, even if we were to raise salaries immediately, because of the long training.
- dluan 11y agoHow timely: this just dropped in the NYTimes today as well, "A Do-It-Yourself Revolution in Diabetes Care". http://www.nytimes.com/2016/02/23/health/a-do-it-yourself-revolution-in-diabetes-care.html http://www.nytimes.com/2016/02/23/health/a-do-it-yourself-re... Featuring the Open Insulin project. Many of the supporters of that project came from HN.
- arafa 11y agoOne of my siblings is a major contributor to Nightscout, it's a great piece of open source software. The makers of the Dexcom software have been stonewalling their efforts, but at least that isn't killing the project. Hopefully something similar can be done for insulin, though that seems a lot more difficult.
- roadnottaken 11y agoI'm a biologist who works in the pharmaceutical industry. I like the idea of open source insulin as much as the next guy. But. I just took a look at their website and it's a complete joke, frankly. It's basically a high-school science experiment. The sort of thing that a single undergrad could do in a few days. Compared to the thousands of man-years required to produce and test a new pharmaceutical product. I wish them luck, but c'mon. Biopharma is not IT where a smart kid can compete from his garage. It just isn't. The NYTimes article says "the hackers hope to be able to demonstrate the technological feasibility" rather than manufacture a drug. But everyone knows that it's technically feasible -- the challenge (and cost) is in the doing.
- dnautics 11y ago"Biopharma is not IT where a smart kid can compete from his garage." Well, I am currently producing one early-stage (xenograft) drug candidate literally in my garage, and have made two new molecules based on the structure, also in my garage, about to be submitted to structural characterization (and eventually, in vitro studies and maybe even xenograft)... But yeah, I do have a PhD in chemistry, and spend 10-20h/wk on the project. (also with the caveat that all my studies hit a "brick wall" of can't do in the garage when I have to start worrying about GMP).
- venomsnake 11y agoCan anyone explain me the evergreening - even if new patent is granted for new molecule the old molecule should be free. So why is nobody producing them?
- mschuster91 11y agoBecause no one is interested in spending billions to get a generic insulin through FDA or other regulatory agencies. Too much profit is to be made.
- venomsnake 11y agoIIRC you don't need to spend billions to get it trough FDA. That is the whole point of the generic. That the molecule is already approved and tested.
- akiselev 11y agoYou don't need to spend money on phase 1-3 trials for safety and efficacy of the molecule but you do still need to spends tens of millions of dollars to prove that the generic drug you are manufacturing behaves like the original, within a margin of error, and that you can maintain that quality control in the future.
- 0xcde4c3db 11y agoIt depends. Sometimes it's simply more profitable to produce something else. Sometimes the market is too small to justify the bioequivalence studies. Sometimes the FDA mysteriously changes its mind on the safety of a drug the same day the patent expires [1]. [1] http://www.npr.org/sections/health-shots/2013/04/17/177602393/why-fdas-rejection-generic-oxycontin-may-have-side-effects http://www.npr.org/sections/health-shots/2013/04/17/17760239...
- Frozenlock 11y ago> except the government paid the bill, not the patient, a bit more civilised but still the problem stay the same (...) God I hate those moral high ground stances seeping everywhere in HN comments. You think it's more civilized, I think it's barbaric to forcefully take something from someone. Just like that, you made it that much harder for me to take anything from what you've written. > (...) second, most people are uneducated about diabetes, they think it concern only fat people or other countries, and other BS like that (...) And the NYTimes article you linked immediately after starts by saying "The prevalence of diabetes has been rising in rich countries for several decades, largely driven by increases in the rate of obesity." Are they totally clueless? >finally, why it is disgusting and criminal for pharma corp to make ppl pay for insulin ? it as simple as that: if you don't take insulin you die, period. Well, gee, it sure sounds like food, water, vitamins, or a bunch of other stuff that are sold for profit everywhere. >It's not curable, there is no alternative diet, nothing, zilch, nada Except that type 2 (the one that is the rise, by your linked article) is preventable. There is a high correlation between type 2 diabetes and sugar intake.
- eropple 11y ago> You think it's more civilized, I think it's barbaric to forcefully take something from someone. Nothing described in the post to which you replied is being forcefully taken from anyone. You live in a society. That society has a social contract, accepted in aggregate by its citizens and periodically subject to shifts--some of them that you may prefer, others that you may not. You cannot unilaterally renegotiate this contract, but you can choose to leave if you don't want to uphold your end of the social contract--literally nobody is stopping you from doing so! If you're an American, renouncing your citizenship is a very easy act that can be done at, IIRC, any consulate. You need not be under the onerous burden of that social contract and its (frankly, meager) expectations of you if you choose not to be. But, statistically, it's almost certain that you won't choose not to be. Because even the very, very rich benefit from statefulness and membership in a functioning society.
- dang 11y agoWe detached this subthread from https://news.ycombinator.com/item?id=11154983 https://news.ycombinator.com/item?id=11154983 and marked it off-topic.
- zwetan 11y agoYou sure do sound like an american who think the american way is the only way. Those poor corporation threatened by the greed of the diabetes people who blatantly try to take advantage of their hard effort to make a buck. Off course that's the fault of those hairy fat bastards of diabetic people, bunch of peasant who can not control their urge for sugary thing, yeah we should make them pay big time for their incurable auto-immune disease, and if they can not pay let them just die in their own filth. Please tattoo "sold for profit" on your forehead.
- dang 11y agoPlease don't post any more uncivil comments. We detached this comment from https://news.ycombinator.com/item?id=11155108 https://news.ycombinator.com/item?id=11155108 and marked it off-topic.
- cfcef 11y agoSome previous submissions: http://www.psmag.com/health-and-behavior/why-is-there-no-generic-insulin http://www.psmag.com/health-and-behavior/why-is-there-no-gen... http://www.psmag.com/health-and-behavior/why-is-there-no-generic-insulin http://www.psmag.com/health-and-behavior/why-is-there-no-gen...
- glenk 11y agoI've been type 1 for over 30 years since I was a toddler. I could stand to lose a few pounds these days, but I am not fat, nor obese. Adjusting my diet would do very little to change the increasingly high amount I spend on insulin. The cost of insulin over the last few years and as recently as the last few months has skyrocketed. Not just the fancy fast acting insulin, but even the regular stuff that you can buy over the counter without a prescription(R and NPH) has nearly quadrupled in the last 12 years. It's not an increase in manufacturing costs. It's price fixing by the two major players(Lilly and Novo). You'd think that with Lilly significantly raising their prices a few months ago, that Novo Nordisk could make a killing, but no, they both did it at the same time. Funny how that worked out.
- bobhaigler 11y agoIf you have a Walmart nearby they carry Novolin R for ~$24/10ml. It's still expensive, but better than the $120 or more for Humulin I was spending at Costco (and still better that the $300 charged at some places).
- glenk 11y agoI hadn't realized there was such a difference between cash price and prescription price. Through work currently we can use a web site to help find your cheapest place for prescriptions. One bottle of Novolin R like you said about is about $25 from Walmart for cash price. One bottle of the same prescription with a discount coupon is $138 dollars. That's still cheaper than Novolog/Humalog, but how in the world is it more expensive to buy insulin with a prescription and insurance than without? When I pay a 20% co-pay am I essentially paying my insurance company the extra money?
- maxerickson 11y agoI think it's because of the pharmacy benefit managers mentioned in the article. You use your card, you pay the negotiated rate that they have with the insurance company. You pay cash, you pay the rate Walmart is willing to sell it at. Of course it makes no sense that the fiddly details of how you buy medicine matter to the tune of 5x. I guess part of the problem is that an awful lot of people are insulated from the costs of their medical care.
- sparky_z 11y ago"This is true, in no small part, because the big three have cleverly extended the lives of their patents, making incremental “improvements” to their insulin." Possibly dumb question: If the improvements really are that minor, what's stopping other companies from using the original, "unimproved" formulation in a generic? How would disallowing the "improved" patents change the situation?
- dragonwriter 11y ago> If the improvements really are that minor, what's stopping other companies from using the original, "unimproved" formulation in a generic? The fact that doctors won't prescribe the unimproved formulation when the improved one is available.
- msie 11y agoThe cost to start a drug company to make generic insulin must be prohibitive enough that we don't see any.
- feld 11y agoMy mom just told me in tears today it cost her over $400 rather than the normal $80-90 copay she was used to
- deleted 11y ago[deleted]
- lgp171188 11y agoI am tempted to believe that the pharma companies are more interested in keeping their recurring revenues from diabetics than find a one time cure. Here in India, the medicines and tools for a diabetic (particulary IDDM) is still prohibitively expensive for most people who have it. The prices of insulins and testing strips have increased by 10% or so many times in the past couple of years. Things like CGMS, insulin pumps are not affordable even to well-off people like me. There has always been news of research from various government and government aided organizations towards the development of low cost testing strips (at about Rs. 5 per strip compared to Rs. 17 and above for the existing products) but nothing has come out as a product. What's worse is an unknown healthcare company has acquired the technology from ICMR (Indian Council of Medical Research) a year back and till now their only product is a low cost sanitary napkin. Wouldn't be surprised of the involvement of the big pharma companies in the delay. All this said, at least India doesn't have an insurance system like in the US which has pushed up the prices repeatedly to help the insurance companies (imho an unwanted middleman in most cases) make more and more money. I am not very optimistic about the future.
- patmcguire 11y agoWhat happened to Genentech? Wasn't this their first product? Didn't this happen in the late 70's? F. Hoffmann-La Roche AG is their parent now, not named.
- adenner 11y agoAt least in some states you can buy a form of insulin over the counter. It is an older formulation and apparently it is not the easiest thing to DYI figure out the correct dose. NPR had a report on it a while back. http://www.npr.org/sections/health-shots/2015/12/14/459047328/you-can-buy-insulin-without-a-prescription-but-should-you http://www.npr.org/sections/health-shots/2015/12/14/45904732...
- skyhatch1 11y agoA fair enough statement: "The broader availability of [over-the-counter] insulin allows patients with diabetes to obtain it "quickly in urgent situations, without delays," the FDA says, and is intended to increase patient safety." However, it seems like there are no visible protocols in place to control use in non-emergency situations like with the patient mentioned in the NYTimes article. That's certainly risky for poorer diabetics who don't necessarily know better, or are desperate enough financially to risk the long-term consequences.
- shade23 11y agoThis project started a while ago[1].This could pretty much change the way people approach medicine. [1]:https://experiment.com/projects/open-insulin https://experiment.com/projects/open-insulin
- pjc50 11y ago> Insulin has been around for almost a century > In the United States, just three pharmaceutical giants hold patents that allow them to manufacture insulin How does this work with patent lifetimes being 25 years? Anyway, as the article says, in countries where chronic medical conditions aren't seen as an opportunity for price-gouging, it costs much less or is free to the user.
- abpavel 11y agoShouldn't it be called patent extension racket?
- tim333 11y agoI see generic Insulin is available in India: Actrapid 40 iu, 10ml at Rs. 145, or about US$2 so the lack of availability would seem to be down to regulatory / patent bs. There should be some way to alter the laws in the US to favour the US people rather than the billionaires. Saunders?
- known 11y agohttp://janaushadhi.gov.in/list_of_medicines.html http://janaushadhi.gov.in/list_of_medicines.html
- d6974 11y agoCheck out Dr Bernstein's Diabetes solution and use less insulin.